Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Dose reduction and discontinuation of non-tumor necrosis factor (TNF) biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) for people with rheumatoid arthritis in remission or low disease activity.
Journal: The Cochrane database of systematic reviews
Published: May 20, 2026
Immune hallmarks of recurrent immune checkpoint inhibitor-mediated inflammatory arthritis.
Journal: Cancer immunology research
Published: December 23, 2025
Toxicity in the era of immune checkpoint inhibitor therapy.
Journal: Frontiers in immunology
Published: June 10, 2024
Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL.
Journal: RMD open
Published: November 02, 2023
Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
Journal: Rheumatology (Oxford, England)
Published: September 29, 2022
A PKM2 signature in the failing heart.
Journal: Biochemical and biophysical research communications
Published: February 06, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026